UAN

CVR Partners, LP (UAN)

Last Price$83.91.6%
Market Cap$895.0M
LTM Revenue
$527.4M
YoY Growth
-29.9%
3Y CAGR
+6.7%
5Y CAGR
+4.8%
Stock quality & Intrinsic value
6/10
4.3% overvalued

CVR Partners, LP Revenue

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Revenue
$263.0M
$208.4M
$180.5M
$302.9M
$302.3M
$323.7M
$298.7M
$289.2M
$356.3M
$330.8M
$351.1M
$404.2M
$350.0M
$532.6M
$835.6M
$681.5M
UAN
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for UAN and see if it's the right time to invest.
Dive in

CVR Partners, LP (UAN) Revenue comparison analysis

Crunching data... Almost there!

UAN key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms

FAQ

1) What is CVR Partners, LP's Revenue?

As of today, CVR Partners, LP's last 12-month Revenue is $527.4M, based on the financial report for Sep 30, 2024 (Q3 2024).

2) What is CVR Partners, LP's Revenue growth rate?

Over the last year, CVR Partners, LP's Revenue growth was (29.9%). The average annual Revenue growth rates for CVR Partners, LP have been 16.2% over the past three years, 4.8% over the past five years.

3) Is CVR Partners, LP's Revenue growth rate Good?

Over the last year, CVR Partners, LP's Revenue growth was (29.9%), which is lower than industry growth of (0.2%). It indicates that CVR Partners, LP's Revenue growth is Bad.

4) How does CVR Partners, LP's Revenue growth rate compare to its peers?

Over the last year, CVR Partners, LP's Revenue growth was (29.9%), which is lower than peer median growth of (19.6%). The list of peers includes NTR, CTVA, MOS, ICL, CF, FMC, SMG, LVRO, BIOX, IPI etc.